Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Conditions: Hyperphosphatemia; End Stage Renal Disease; ESRD Interventions: Drug: Ferric Citrate; Drug: Sevelamer Carbonate Sponsors: Panion & BF Biotech Inc.; Shandong Weigao Panion Pharmaceutical Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Chronic Kidney Disease | Dialysis | Hemodialysis | Research | Urology & Nephrology